Table 3. Scoring cells treated with standard pertussis toxin concentrations for CHO cell clustering by microscopy and xCELLigence.
Method | Experiment | Standard PT (IU/mL) a | PT Endpoint Conc (IU/mL) | PT Median endpoint Conc (IU/mL) (expected variability range) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
2 | 1 | 0.5 | 0.25 | 0.125 | 0.063 | 0.031 | 0.016 | ||||
Microscopy | 1 | + | + | + | + | - | - | - | - | 0.25 | 0.25 (0.125–0.5) |
2 | + | + | + | + | - | - | - | - | 0.25 | ||
3-replicate 1 | + | + | + | + | + | - | - | - | 0.125 | ||
3-replicate 2 | + | + | + | + | - | - | - | - | 0.25 | ||
4-replicate 1 | + | + | + | + | + | - | - | - | 0.125 | ||
4-replicate 2 | + | + | + | + | + | - | - | - | 0.125 | ||
5-replicate 1 | + | + | + | + | - | - | - | - | 0.25 | ||
5-replicate 2 | + | + | + | + | - | - | - | - | 0.25 | ||
xCELLigence | 1 | + | + | + | + | + | - | - | - | 0.125 | 0.125 (0.063–0.25) |
2 | + | + | + | + | + | - | - | - | 0.125 | ||
3-replicate 1 | + | + | + | + | + | - | - | - | 0.125 | ||
3-replicate 2 | + | + | + | + | + | - | - | - | 0.125 | ||
4-replicate 1 | + | + | + | + | + | - | - | - | 0.125 | ||
4-replicate 2 | + | + | + | + | + | + | - | - | 0.063 | ||
5-replicate 1 | + | + | + | + | + | - | - | - | 0.125 | ||
5-replicate 2 | + | + | + | + | + | - | - | - | 0.125 |
a Results after 48 h of incubation.
“-”: Negative for cell clustering (Microscopy: ≥ 80% cell clustering per well; xCELLigence: Relative cell index ≤ 65%).
“+”: Positive for cell clustering (Microscopy: < 80% cell clustering per well; xCELLigence: Relative cell index > 65%).
Endpoint Conc: Endpoint concentration, last concentration of standard PT to show a positive response.
Expected variability range: Plus or minus one two-fold dilution of the median.